Article

Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants

2021-03-16

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants of concern (VOC), such as Delta (B.1.617.2) and Omicron (B.1.1.529), has continued to drive the worldwide pandemic. Therefore, there is a high demand for vaccines with enhanced efficacy, high thermostability, superior design flexibility, and fast manufacturing speed. Here, we report a circular RNA (circRNA) vaccine that encodes...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8b05d0c1-c144-5dec-bda5-34f65ef43e26
DOI: 10.1101/2021.03.16.435594

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Circular RNA Vaccines against SARS-CoV-2 and Emerging VariantsDOI 10.1101/2021.03.16.435594Read

Circular RNA vaccines against SARS-CoV-2 and emerging variantsSemantic proximity Read

A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stabilitySemantic proximity Read

Vaccines’ New Era-RNA VaccineSemantic proximity Read

Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines against SARS-CoV-2Semantic proximity Read

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2Semantic proximity Read

Delivery of Circular mRNA via Degradable Lipid Nanoparticles against SARS-CoV-2 Delta VariantSemantic proximity Read

Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2Semantic proximity Read

Next‐Generation Vaccines: Nanovaccines in the Fight against SARS‐CoV‐2 Virus and beyond SARS‐CoV‐2Semantic proximity Read

Circular RNA vaccine in disease prevention and treatmentSemantic proximity Read

Self-Amplifying RNA: A Second Revolution of mRNA Vaccines against COVID-19Semantic proximity Read

mRNA Vaccines: Design Principles, Mechanisms, and Manufacturing—Insights From COVID‐19 as a Model for Combating Infectious DiseasesSemantic proximity Read

Preclinical evaluation of RQ3013, a broad-spectrum mRNA vaccine against SARS-CoV-2 variantsSemantic proximity Read